drugset / Trial / NCT05144360
Efficacy and Safety of Atenas Association in the Treatment of Type II Diabetes Mellitus and Hypertension
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to evaluate the efficacy and safety of Atenas association in the treatment of type 2 diabetes mellitus and hypertension
Timeline
- Start
- 2022-08
- Primary completion
- 2024-07
- Completion
- 2024-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Amlodipine | Other / unclassified | 5 mg | Oral |
| Subject | Atenas | Unknown | — | Oral |
| Comparator | Empagliflozin | Small molecule | 25 mg | Oral |
| Comparator | Telmisartan | Other / unclassified | 40 mg | Oral |
| Comparator | Telmisartan | Other / unclassified | 80 mg | Oral |